NO980419L - Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst - Google Patents

Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst

Info

Publication number
NO980419L
NO980419L NO980419A NO980419A NO980419L NO 980419 L NO980419 L NO 980419L NO 980419 A NO980419 A NO 980419A NO 980419 A NO980419 A NO 980419A NO 980419 L NO980419 L NO 980419L
Authority
NO
Norway
Prior art keywords
triazole derivatives
cancer growth
inhibit cancer
growth
agents
Prior art date
Application number
NO980419A
Other languages
English (en)
Other versions
NO980419D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO980419D0 publication Critical patent/NO980419D0/no
Publication of NO980419L publication Critical patent/NO980419L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Farmasøytisk preparat som inhiberer veksten av tumorer og cancere i pattedyr og som omfatter et 1H-1,2,4-triazolderivat sammen med en sikker og effektiv mengde av et kjemoterapeu- tisk middel. Potensierende midler kan anvendes for å øke effektiviteten av legemidlene. Triazolene og de potensieren- de midler kan også anvendes for å behandle virusinfeksjoner.
NO980419A 1995-08-03 1998-01-30 Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst NO980419L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US183895P 1995-08-03 1995-08-03
US08/674,182 US6200992B1 (en) 1995-06-07 1996-07-16 Pharmaceutical composition for inhibiting the growth of cancers
PCT/US1996/012473 WO1997005872A2 (en) 1995-08-03 1996-07-30 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
NO980419D0 NO980419D0 (no) 1998-01-30
NO980419L true NO980419L (no) 1998-04-02

Family

ID=26669546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980419A NO980419L (no) 1995-08-03 1998-01-30 Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst

Country Status (17)

Country Link
US (3) US6200992B1 (no)
EP (1) EP0841920A2 (no)
JP (1) JPH11510186A (no)
KR (1) KR19990036136A (no)
CN (1) CN1192142A (no)
AR (1) AR003174A1 (no)
AU (1) AU709007B2 (no)
BR (1) BR9609987A (no)
CA (1) CA2228502A1 (no)
CZ (1) CZ30698A3 (no)
IL (1) IL123093A0 (no)
MX (1) MX9800944A (no)
NO (1) NO980419L (no)
PL (1) PL324888A1 (no)
SK (1) SK14098A3 (no)
TR (1) TR199800245T2 (no)
WO (1) WO1997005872A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
BR0114713A (pt) * 2000-10-16 2004-01-13 Neopharm Inc Formulação lipossÈmica de mitoxantrona
CN1311872C (zh) * 2004-12-29 2007-04-25 山东蓝金生物工程有限公司 一种抗癌药物组合物
US8722014B2 (en) 2009-05-01 2014-05-13 Washington University 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
CN102552274B (zh) * 2010-11-12 2013-10-23 姚雪彪 动点马达蛋白小分子抑制剂在抑制肿瘤细胞增殖中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
DE3262386D1 (en) 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4490540A (en) 1981-09-14 1984-12-25 Janssen Pharmaceutica N.V. (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
EP0196855A3 (en) 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
US5211736A (en) 1988-05-09 1993-05-18 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
DE3837463A1 (de) 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5114951A (en) 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
BE1004029A6 (nl) 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5360612A (en) 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration
US5770616A (en) * 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
AU6683296A (en) 1997-03-05
WO1997005872A2 (en) 1997-02-20
NO980419D0 (no) 1998-01-30
WO1997005872A3 (en) 1997-03-27
AR003174A1 (es) 1998-07-08
CN1192142A (zh) 1998-09-02
BR9609987A (pt) 1999-01-12
TR199800245T2 (xx) 1998-10-21
MX9800944A (es) 1998-04-30
CZ30698A3 (cs) 1998-06-17
KR19990036136A (ko) 1999-05-25
JPH11510186A (ja) 1999-09-07
US6110953A (en) 2000-08-29
EP0841920A2 (en) 1998-05-20
AU709007B2 (en) 1999-08-19
SK14098A3 (en) 1998-09-09
US6200992B1 (en) 2001-03-13
PL324888A1 (en) 1998-06-22
IL123093A0 (en) 1998-09-24
CA2228502A1 (en) 1997-02-20
US20010047015A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
NO980419L (no) Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
NO975662L (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
NO975661L (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
CA2255951A1 (en) Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
PL308217A1 (en) Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
MY116478A (en) Tri-substituted imidazoles having multiple therapeutic properties
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
UA50719C2 (uk) Проліки для терапії пухлин і запальних захворювань
NO980473L (no) Anvendelse av flukonazol for å inhibere cancervekst
NZ308789A (en) Tetralin derivatives and medicaments
MX9800945A (es) Uso de griseofulvina para inhibir el crecimiento de canceres.
NO974696D0 (no) Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer
SI0841912T1 (en) Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
RU94046300A (ru) Химические соединения, способ их получения, фармкомпозиция, способ лечения, промежуточный продукт
ES8406191A1 (es) Procedimiento para la obtencion de un medio antiviral
ATE248163T1 (de) Neuartige, pharmazeutisch aktive verbindung
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
MX9709712A (es) Uso de derivados de 1,2,4-triazol para la manufactura de un medicamento para el tratamiento de canceres.
MX9709530A (es) Uso de bis-1,2.4-triazoles para la manufactura de un medicamento para el tratamiento de canceres.
HUP9801596A3 (en) Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them
MX9701529A (es) Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application